These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4762281)

  • 61. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gas transfer and thrombogenesis in an annular membrane oxygenator with active blood mixing.
    Gaylor JD; Murphy JF; Caprini JA; Zukerman L; Mockros LF
    Trans Am Soc Artif Intern Organs; 1973; 19():516-24. PubMed ID: 4805841
    [No Abstract]   [Full Text] [Related]  

  • 63. [Use of the new thrombolytic substance plasmakinase to treat acute experimental coronary artery thrombosis].
    Khvatov VB; Galankina IE; Maksimovich IV
    Grudn Khir; 1983; (4):22-32. PubMed ID: 6354883
    [No Abstract]   [Full Text] [Related]  

  • 64. Intraoperative anticoagulation during arterial reconstructive procedures.
    Lee BY; Thoden WR; Mc Cann WJ; Madden JL; Del Guercio LR; Berkowitz P
    Surg Gynecol Obstet; 1982 Dec; 155(6):809-12. PubMed ID: 7147159
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 66. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polyphloretinphosphate, an antithrombogenic substance which inhibits platelet adhesion.
    Swedenborg J; Olsson P; Lagergren H
    Thromb Res; 1974 May; 4(5):687-98. PubMed ID: 4838248
    [No Abstract]   [Full Text] [Related]  

  • 68. Management of thrombosis during pregnancy.
    Inbal A
    Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
    [No Abstract]   [Full Text] [Related]  

  • 69. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM
    Vasa Suppl; 1973; 1():1-18. PubMed ID: 4517911
    [No Abstract]   [Full Text] [Related]  

  • 70. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
    Collen D; Lu HR; Stassen JM; Vreys I; Yasuda T; Bunting S; Gold HK
    Thromb Haemost; 1994 Jan; 71(1):95-102. PubMed ID: 8165652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
    Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
    Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Controlled trial of ancrod and streptokinase in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Williams EW; Walker MW; Chesterman CN; Holt JM; Sharp AA
    Br J Haematol; 1974 Jul; 27(3):407-14. PubMed ID: 4606388
    [No Abstract]   [Full Text] [Related]  

  • 73. The management of pulmonary embolic disease.
    Thomas DP
    Am J Med Sci; 1970 Mar; 259(3):157-63. PubMed ID: 4917972
    [No Abstract]   [Full Text] [Related]  

  • 74. The thrombolytic effect of heparin and a heparin-like substance, SP 54.
    Fitz Gerald DE; Szeto IL; Spero J; Lewis JH
    Thromb Diath Haemorrh; 1967 May; 17(3-4):418-22. PubMed ID: 5589298
    [No Abstract]   [Full Text] [Related]  

  • 75. Early reparative process of implanted arterial prosthesis: a morphological and hematological study.
    Takebayashi J; Kamatani M; Namba S; Katagami Y; Hayashi K
    J Surg Res; 1974 Aug; 17(2):102-10. PubMed ID: 4277446
    [No Abstract]   [Full Text] [Related]  

  • 76. Thrombosis, atherosclerosis, and endothelium.
    Spaet TH; Gaynor E; Stemerman MB
    Am Heart J; 1974 May; 87(5):661-8. PubMed ID: 4594475
    [No Abstract]   [Full Text] [Related]  

  • 77. [Tricholysine-induced histological changes in experimental thrombosis].
    Gavrilov OK; Glasko EN; Murashova NS; Siretenko AV; Subbotina LA
    Gematol Transfuziol; 1983 Aug; 28(8):50-2. PubMed ID: 6354831
    [No Abstract]   [Full Text] [Related]  

  • 78. Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
    Olsson P; Blombäck M; Egberg N; Ekeström S
    Thromb Res; 1976 Sep; 9(3):277-87. PubMed ID: 982350
    [No Abstract]   [Full Text] [Related]  

  • 79. [EFFECT OF SNAKE VENOMS ON BLOOD COAGULATION IN VITRO].
    KORNALIK F
    Acta Univ Carol Med (Praha); 1963; 9():149-88. PubMed ID: 14166155
    [No Abstract]   [Full Text] [Related]  

  • 80. Coagulant activity deposited on the Kiil haemodialysis membranes.
    Lurie A; Denson KW
    Thromb Diath Haemorrh; 1970 Dec; 24(3):572-6. PubMed ID: 5534488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.